Breaking News
SICKLE CELL DISEASE | FDA Grants Orphan Drug Designation to AND017
TIF STUDY | Desferioxamine Usage Survey
COUNTRIES | The Maldives Launches Thalassaemia-Specialized Hospital and 10-Year Strategic Disease Plan
Splenectomy as Treatment for Primary Warm Autoimmune Hemolytic Anemia (wAIHA)
WHAT YOU NEED TO KNOW | EMA Recommends Suspension of Pfizer’s Sickle Cell Disease Drug Oxbryta
APLASTIC ANEMIA | Hetrombopag Achieves Significant Hematological Responses in Newly Diagnosed Patients
THALASSAEMIA WEBINAR FOR ASEAN & OCEANIA HEALTHCARE PROFESSIONALS | 21 October 2024
UNITING EXPERTS | Highlights from the 1st Nordic Red Blood Cell Meeting
ANNUAL REPORT 2023 | Unveiling TIF’s Impactful Achievements
WORLD PATIENT SAFETY DAY 2024 | Get It Right, Make It Safe!
English
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Home
/
Newsletter
Newsletter
3 weeks ago
TIF Newsletter – September 2024
Read More »
July 12, 2024
TIF Newsletter – June 2024
Read More »
January 2, 2024
TIF Newsletter – December 2023
Read More »
November 9, 2023
TIF Newsletter – October 2023
Read More »
September 4, 2023
TIF Newsletter – August 2023
Read More »
July 6, 2023
TIF Newsletter – June 2023
Read More »
December 30, 2022
TIF Newsletter – December 2022
Read More »
November 7, 2022
TIF Newsletter – October 2022
Read More »
September 1, 2022
TIF Newsletter – August 2022
Read More »
January 15, 2021
TIF Newsletter – December 2020
Read More »
Next page
Back to top button
Close
Search for